- Home
- ZVRA vs GLRE Comparison
ZVRA vs GLRE Comparison
Compare ZVRA & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- GLRE
- Stock Information
- Founded
- ZVRA 2006
- GLRE 2004
- Country
- ZVRA United States
- GLRE Cayman Islands
- Employees
- ZVRA N/A
- GLRE N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- GLRE Property-Casualty Insurers
- Sector
- ZVRA Health Care
- GLRE Finance
- Exchange
- ZVRA Nasdaq
- GLRE Nasdaq
- Market Cap
- ZVRA 481.7M
- GLRE 480.7M
- IPO Year
- ZVRA 2015
- GLRE 2007
- Fundamental
- Price
- ZVRA $11.05
- GLRE $12.79
- Analyst Decision
- ZVRA Strong Buy
- GLRE
- Analyst Count
- ZVRA 9
- GLRE 0
- Target Price
- ZVRA $23.25
- GLRE N/A
- AVG Volume (30 Days)
- ZVRA 1.2M
- GLRE 124.6K
- Earning Date
- ZVRA 08-12-2025
- GLRE 08-04-2025
- Dividend Yield
- ZVRA N/A
- GLRE N/A
- EPS Growth
- ZVRA N/A
- GLRE N/A
- EPS
- ZVRA N/A
- GLRE 1.32
- Revenue
- ZVRA $40,588,000.00
- GLRE $717,617,000.00
- Revenue This Year
- ZVRA $303.00
- GLRE N/A
- Revenue Next Year
- ZVRA $77.66
- GLRE N/A
- P/E Ratio
- ZVRA N/A
- GLRE $9.69
- Revenue Growth
- ZVRA 46.47
- GLRE 2.79
- 52 Week Low
- ZVRA $6.19
- GLRE $11.95
- 52 Week High
- ZVRA $13.16
- GLRE $15.82
- Technical
- Relative Strength Index (RSI)
- ZVRA 50.02
- GLRE 31.63
- Support Level
- ZVRA $10.69
- GLRE $13.04
- Resistance Level
- ZVRA $11.37
- GLRE $13.48
- Average True Range (ATR)
- ZVRA 0.49
- GLRE 0.30
- MACD
- ZVRA -0.21
- GLRE -0.02
- Stochastic Oscillator
- ZVRA 12.50
- GLRE 15.63
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.